Literature DB >> 25590514

State laws, syringe exchange, and HIV among persons who inject drugs in the United States: History and effectiveness.

Heidi Bramson1, Don C Des Jarlais1, Kamyar Arasteh1, Ann Nugent1, Vivian Guardino1, Jonathan Feelemyer1, Derek Hodel2.   

Abstract

In 1981, when acquired immune deficiency syndrome (AIDS) was first observed among persons who inject drugs, almost all US states had laws criminalizing the possession and distribution of needles and syringes for injecting illicit drugs. We reviewed changes to these laws to permit 'syringe exchanges' and the provision of public funding for such programs. Most of the changes in law occurred during the 1990s, 5-10 years later than in many other countries. Public funding of syringe exchanges is associated with lower rates of human immunodeficiency virus (HIV) infection, greater numbers of syringes distributed (a possible causal mechanism), and greater numbers of health and social services provided. Experience in the United states may prove useful in other countries: state, provincial, and local governments may need to move ahead of central governments in addressing HIV infection among persons who inject drugs.

Entities:  

Mesh:

Year:  2015        PMID: 25590514     DOI: 10.1057/jphp.2014.54

Source DB:  PubMed          Journal:  J Public Health Policy        ISSN: 0197-5897            Impact factor:   2.222


  24 in total

1.  Evaluating effectiveness of syringe exchange programmes: current issues and future prospects.

Authors:  F I Bastos; S A Strathdee
Journal:  Soc Sci Med       Date:  2000-12       Impact factor: 4.634

2.  Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed.

Authors:  Louisa Degenhardt; Bradley Mathers; Peter Vickerman; Tim Rhodes; Carl Latkin; Matt Hickman
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

3.  Drugs and violence: causes, correlates, and consequences.

Authors: 
Journal:  NIDA Res Monogr       Date:  1990

4.  Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.

Authors:  Joanne E Brady; Samuel R Friedman; Hannah L F Cooper; Peter L Flom; Barbara Tempalski; Karla Gostnell
Journal:  J Urban Health       Date:  2008-03-15       Impact factor: 3.671

Review 5.  Rapid scale up of harm reduction in China.

Authors:  Sheena G Sullivan; Zunyou Wu
Journal:  Int J Drug Policy       Date:  2007-02-14

Review 6.  Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review.

Authors:  Bradley M Mathers; Louisa Degenhardt; Benjamin Phillips; Lucas Wiessing; Matthew Hickman; Steffanie A Strathdee; Alex Wodak; Samiran Panda; Mark Tyndall; Abdalla Toufik; Richard P Mattick
Journal:  Lancet       Date:  2008-09-23       Impact factor: 79.321

7.  The legal environment impeding access to sterile syringes and needles: the conflict between law enforcement and public health.

Authors:  L O Gostin
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

8.  Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco.

Authors:  R N Bluthenthal; A H Kral; J Lorvick; J K Watters
Journal:  Med Anthropol       Date:  1997-12

9.  Harm reduction headway and continuing resistance: insights from safe injection in the city of Vancouver.

Authors:  Andrew D Hathaway; Kirk I Tousaw
Journal:  Int J Drug Policy       Date:  2008-02

10.  Combined HIV prevention, the New York City condom distribution program, and the evolution of safer sex behavior among persons who inject drugs in New York City.

Authors:  D C Des Jarlais; K Arasteh; C McKnight; J Feelemyer; H Hagan; H L F Cooper; D C Perlman
Journal:  AIDS Behav       Date:  2014-03
View more
  17 in total

1.  Expanding low-threshold buprenorphine to justice-involved individuals through mobile treatment: Addressing a critical care gap.

Authors:  Noa Krawczyk; Megan Buresh; Michael S Gordon; Thomas R Blue; Michael I Fingerhood; Deborah Agus
Journal:  J Subst Abuse Treat       Date:  2019-05-09

Review 2.  HIV Testing, Care, and Treatment Among Women Who Use Drugs From a Global Perspective: Progress and Challenges.

Authors:  Lisa Metsch; Morgan M Philbin; Carrigan Parish; Karen Shiu; Jemima A Frimpong; Le Minh Giang
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

Review 3.  Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.

Authors:  David H Cloud; Tessie Castillo; Lauren Brinkley-Rubinstein; Manisha Dubey; Robert Childs
Journal:  Curr HIV/AIDS Rep       Date:  2018-06       Impact factor: 5.071

4.  Motivation to Change and Treatment Participation Among Syringe Service Program Utilizers in Rural Kentucky.

Authors:  Hilary L Surratt; Janet K Otachi; Timothy Williams; Jennifer Gulley; A Scott Lockard; Rebecca Rains
Journal:  J Rural Health       Date:  2019-08-15       Impact factor: 4.333

5.  Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?

Authors:  Molly Doernberg; Noa Krawczyk; Deborah Agus; Michael Fingerhood
Journal:  Subst Abus       Date:  2019-04-22       Impact factor: 3.716

Review 6.  The American Opioid Epidemic in Special Populations: Five Examples.

Authors:  Carlos Blanco; Mir M Ali; Aaron Beswick; Karen Drexler; Cheri Hoffman; Christopher M Jones; Tisha R A Wiley; Allan Coukell
Journal:  NAM Perspect       Date:  2020-10-26

7.  Associations of place characteristics with HIV and HCV risk behaviors among racial/ethnic groups of people who inject drugs in the United States.

Authors:  Sabriya L Linton; Hannah L F Cooper; Mary E Kelley; Conny C Karnes; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Samuel R Friedman; Don Des Jarlais; Salaam Semaan; Barbara Tempalski; Catlainn Sionean; Elizabeth DiNenno; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  Ann Epidemiol       Date:  2016-08-08       Impact factor: 3.797

8.  Estimated effect of US state syringe sale policy on source of last-used injection equipment.

Authors:  Patrick Janulis; Barrett W Montgomery; James C Anthony
Journal:  Int J Drug Policy       Date:  2019-12-13

9.  HIV Pre-exposure Prophylaxis for People Who Inject Drugs: The Context of Co-occurring Injection- and Sexual-Related HIV Risk in the U.S. Northeast.

Authors:  Alberto Edeza; Angela Bazzi; Peter Salhaney; Dea Biancarelli; Ellen Childs; Matthew J Mimiaga; Mari-Lynn Drainoni; Katie Biello
Journal:  Subst Use Misuse       Date:  2019-10-09       Impact factor: 2.164

10.  Risk Environments, Race/Ethnicity, and HIV Status in a Large Sample of People Who Inject Drugs in the United States.

Authors:  Hannah L F Cooper; Sabriya Linton; Mary E Kelley; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Maria Zlotorzynska; Josalin Hunter-Jones; Samuel R Friedman; Don C Des Jarlais; Barbara Tempalski; Elizabeth DiNenno; Dita Broz; Cyprian Wejnert; Gabriela Paz-Bailey
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.